Your search for smoking cessation returned 18 results

Study shows that all behavioral outcomes favor e-cigarette users across the motivational spectrum for quitting.

Cytisinicline well tolerated with only 2.9% of participants discontinuing due to an adverse event.

No significant difference in verified 7-day abstinence seen by treatment group among Black adults who smoke daily.

The Nicotrol Inhaler (nicotine inhalation system) has been discontinued by Pfizer.

The placebo-controlled ORCA-2 study evaluated the safety and efficacy of cytisinicline as a treatment for smoking cessation in 810 adult smokers.

Combination of a patch and fast-acting nicotine replacement therapy also effective.

Study reveals other smoking cessation aids are tied to more successful quits

Combining varenicline with nicotine patch, extending treatment from 12 to 24 weeks did not increase smoking cessation rates

Significant direct association seen between estrogen use, progestogen use, combined hormone therapy with gastroesophageal reflux disease.

Reviewers discussed new and conventional therapies for lupus nephritis and the prospect of precision medicine.